94 related articles for article (PubMed ID: 1336513)
1. Hepatocellular carcinoma. Prognostic factors and survival analysis in 135 Italian patients.
Rosellini SR; Arienti V; Nanni O; Ugenti F; Tassinari M; Camporesi C; Boriani L; Versari G; Costa PL; Amadori D
J Hepatol; 1992 Sep; 16(1-2):66-72. PubMed ID: 1336513
[TBL] [Abstract][Full Text] [Related]
2. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.
Tangkijvanich P; Anukulkarnkusol N; Suwangool P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
J Clin Gastroenterol; 2000 Dec; 31(4):302-8. PubMed ID: 11129271
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.
Riestra S; Rodriguez M; Delgado M; Suárez A; González N; de la Mata M; Diaz G; Miño-Fugarolas G; Rodrigo L
J Clin Gastroenterol; 1998 Apr; 26(3):200-3. PubMed ID: 9600369
[TBL] [Abstract][Full Text] [Related]
5. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Farinati F; Vitale A; Spolverato G; Pawlik TM; Huo TL; Lee YH; Frigo AC; Giacomin A; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Biasini E; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Masotto A; Trevisani F; Cillo U;
PLoS Med; 2016 Apr; 13(4):e1002006. PubMed ID: 27116206
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of hepatocellular carcinoma: a multivariate analysis in 113 patients].
Ychou M; Veyrac M; Hanslik B; Abouhafss M; Daures JP; Perney P; Pinto J; Bruel JM; Blanc F; Michel H
Bull Cancer; 1995 Nov; 82(11):971-4. PubMed ID: 8535024
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of untreated hepatocellular carcinoma.
Giannini EG; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Benvegnù L; Caturelli E; Zoli M; Borzio F; Chiaramonte M; Trevisani F;
Hepatology; 2015 Jan; 61(1):184-90. PubMed ID: 25234419
[TBL] [Abstract][Full Text] [Related]
11. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
[TBL] [Abstract][Full Text] [Related]
12. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Lerose R; Molinari R; Rocchi E; Manenti F; Villa E
Eur J Cancer; 2001 Jan; 37(2):239-45. PubMed ID: 11166152
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Mazzanti R; Arena U; Pantaleo P; Antonuzzo L; Cipriani G; Neri B; Giordano C; Lanini F; Marchetti S; Gentilini P
Can J Gastroenterol; 2004 Oct; 18(10):611-8. PubMed ID: 15497001
[TBL] [Abstract][Full Text] [Related]
14. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
15. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma.
Ramacciato G; Mercantini P; Cautero N; Corigliano N; Di Benedetto F; Quintini C; Ercolani G; Varotti G; Ziparo V; Pinna AD
Ann Surg Oncol; 2005 Apr; 12(4):289-97. PubMed ID: 15827681
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Castellano L; Calandra M; Del Vecchio Blanco C; de Sio I
J Hepatol; 1997 Nov; 27(5):862-70. PubMed ID: 9382974
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.
Chaminda SR; Suchintha T; Anuk NM; Supun DA; Bhagya GM; Habarakada LCA; Janaka SH
BMC Gastroenterol; 2017 Dec; 17(1):142. PubMed ID: 29207969
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
[TBL] [Abstract][Full Text] [Related]
19. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).
Trevisani F; De Notariis S; Rapaccini G; Farinati F; Benvegnù L; Zoli M; Grazi GL; Del PP; Di N; Bernardi M;
Am J Gastroenterol; 2002 Mar; 97(3):734-44. PubMed ID: 11922571
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of hepatocellular carcinoma. Multifactorial analysis of 84 cases].
Razafimahaleo A; Burtin P; Joly JP; Dupas JL; Capron-Chivrac D; Capron JP
Gastroenterol Clin Biol; 1993; 17(8-9):564-9. PubMed ID: 8253313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
